Home Evaluation of serum alkaline phosphatase measurement through the 4-year trueness verification program in China
Article
Licensed
Unlicensed Requires Authentication

Evaluation of serum alkaline phosphatase measurement through the 4-year trueness verification program in China

  • Jing Wang , Yufei Wang , Tianjiao Zhang , Jie Zeng , Haijian Zhao , Qi Guo , Ying Yan , Jiangtao Zhang , Weiyan Zhou , Wenxiang Chen and Chuanbao Zhang EMAIL logo
Published/Copyright: September 18, 2018

Abstract

Background

Alkaline phosphatase (ALP) is critical for various diseases. The International Federation of Clinical Chemistry and Laboratory Medicine had recommended the new reference procedure in 2011, but many manufacturers did not trace results to the higher procedure. Since 2012, the National Center for Clinical Laboratories (NCCL) in China has organized the trueness verification program (TV) with commutable materials. The present study summarizes the 4-year TV program to give an overview of the measurement standardization for ALP results.

Methods

Commutable serum-based materials with different concentrations were prepared and sent to participating laboratories. The target values were assigned by the reference lab network.

Results

The analytical performance was evaluated according to three indexes: trueness (bias), imprecision (CV) and accuracy (total error [TE]). The number of participating laboratories increased from 115 in 2012 to 287 in 2016. The pass rates of precision for homogeneous and heterogeneous systems were all above 85% over the 4 years; however, the pass rates of bias were much lower (<50%). Among the homogeneous systems, Roche Cobas/Modular had an obvious negative bias, whereas the mean positive bias for Beckman AU was prominent. As to the heterogeneous systems, the pass rates of bias for Sichuan Maccura (57.1%–78.6%) were higher than Roche Cobas/Modular (4.4%–33.9%) and Beckman AU (35.7%–64.8%).

Conclusions

The PT/EQA program with commutable materials can be used to assess the trueness against target values assigned by reference procedures. For ALP, homogeneous systems did not perform better than heterogeneous systems. The bias for ALP performance was notable and was the main obstacle to its standardization in China.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: The Leaping Development Project of Beijing Biomedical Industry (Z161100001816043). The National High Technology Research and Development Program of China (2011AA02A102).

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Schumann G, Klauke R, Canalias F, Bossert-Reuther S, Franck PF, Gella FJ, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 9: reference procedure for the measurement of catalytic concentration of alkaline phosphatase. Clin Chem Lab Med 2011;49:1439–46.10.1515/CCLM.2011.621Search in Google Scholar PubMed

2. Infusino I, Frusciante E, Braga F, Panteghini M. Progress and impact of enzyme measurement standardization. Clin Chem Lab Med 2016;55:334–40.10.1515/cclm-2016-0661Search in Google Scholar PubMed

3. Database of higher-order reference materials, measurement methods/procedures and services. http://www.bipm.org/jctlm/home.do. Assessed: 8 February 2018.Search in Google Scholar

4. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Off J Eur Commun 1998;331:1–37.Search in Google Scholar

5. Panteghini M. Implementation of standardization in clinical practice: not always an easy task. Clin Chem Lab Med 2012;50:1237–41.10.1515/cclm.2011.791Search in Google Scholar PubMed

6. Ge M, Zhao H, Yan Y, Zhang T, Zeng J, Zhou W, et al. Performance of electrolyte measurements assessed by a trueness verification program. Clin Chem Lab Med 2016;54:1319–27.10.1515/cclm-2015-1110Search in Google Scholar PubMed

7. CLSI. Characterization and qualification of commutable reference materials for laboratory medicine; approved guideline. CLSI document C53-A. Wayne (PA): CLSI, 2010.Search in Google Scholar

8. Westgard Quality Control. Westgard QC desirable biological variation database specifications. https://www.westgard.com/biodatabase1.htm. Assessed: 8 Feb 2018.Search in Google Scholar

9. Braga F, Frusciante E, Infusino I, Aloisio E, Guerra E, Ceriotti F, et al. Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories. Clin Chem Lab Med 2017;55:e47–50.10.1515/cclm-2016-0605Search in Google Scholar PubMed

10. Tietz N, Rinker AD, Shaw LM. IFCC methods for the measurement of catalytic concentration of enzymes. Part 5. IFCC method for alkaline phosphatase. J Clin Chem Clin Biochem 1983;21:731–48.Search in Google Scholar

11. Wang Y, Jing W, Zhao H, Zhang J, Zeng J, Zhou W, et al. Assessment of enzyme measurement procedures in China through a trueness verification program. Clin Chim Acta 2016;461:98–102.10.1016/j.cca.2016.07.008Search in Google Scholar PubMed

12. Han L, Wang J, Li Y, Zheng S, Lin H, Huang X, et al. Application of new reference procedure for ALP measurement in the clinical laboratory. Clin Lab 2015;61:445–52.10.7754/Clin.Lab.2014.141117Search in Google Scholar

13. Goossens K, Van Uytfanghe K, Thienpont LM. Trueness and comparability assessment of widely used assays for 5 common enzymes and 3 electrolytes. Clin Chim Acta 2015;442:44–5.10.1016/j.cca.2015.01.009Search in Google Scholar PubMed

Received: 2018-02-26
Accepted: 2018-05-03
Published Online: 2018-09-18
Published in Print: 2018-11-27

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Observing an analyzer’s operational life cycle: a useful management tool for clinical laboratories
  4. Reviews
  5. Personalized laboratory medicine: a patient-centered future approach
  6. Circular RNAs: a new class of biomarkers as a rising interest in laboratory medicine
  7. Mini Review
  8. Impact of interactions between drugs and laboratory test results on diagnostic test interpretation – a systematic review
  9. Opinion Paper
  10. Uncertainty in measurement and total error: different roads to the same quality destination?
  11. Guidelines and Recommendations
  12. Joint EFLM-COLABIOCLI Recommendation for venous blood sampling
  13. General Clinical Chemistry and Laboratory Medicine
  14. Evidence for the positive impact of ISO 9001 and ISO 15189 quality systems on laboratory performance – evaluation of immunohaematology external quality assessment results during 19 years in Austria
  15. Effects of high-dose, intravenous lipid emulsion on laboratory tests in humans: a randomized, placebo-controlled, double-blind, clinical crossover trial
  16. Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
  17. Failure rate prediction of equipment: can Weibull distribution be applied to automated hematology analyzers?
  18. Evaluation of serum alkaline phosphatase measurement through the 4-year trueness verification program in China
  19. Increased serum concentrations of soluble ST2 predict mortality after burn injury
  20. The clinical significance of borderline results of the Elia CTD Screen assay
  21. Reference Values and Biological Variations
  22. Reference intervals for 33 biochemical analytes in healthy Indian population: C-RIDL IFCC initiative
  23. Cancer Diagnostics
  24. BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia
  25. Cardiovascular Diseases
  26. The correlation between glucose fluctuation from self-monitored blood glucose and the major adverse cardiac events in diabetic patients with acute coronary syndrome during a 6-month follow-up by WeChat application
  27. Diabetes
  28. Impact of blood cell counts and volumes on glucose concentration in uncentrifuged serum and lithium-heparin blood tubes
  29. Letters to the Editor
  30. Standard process-oriented workflow introduces pre-analytical error when used in large study sample batches
  31. Comparison of three staining methods in the automated digital cell imaging analyzer Sysmex DI-60
  32. Detection of Plasmodium falciparum using automated digital cell morphology analyzer Sysmex DI-60
  33. Serum ischemia-modified albumin concentration may reflect long-term hypoxia in chronic respiratory disease: a pilot study
  34. Wet absorptive microsampling at home for HbA1c monitoring in diabetic children
  35. Serum endocan levels in patients with chronic obstructive pulmonary disease: a potential role in the evaluation of susceptibility to exacerbation
  36. Analytical and clinical validation of the new Roche Elecsys Vitamin D Total II assay
  37. Analytical validation of two second generation thyroglobulin immunoassays (Roche and Thermo Fisher)
  38. Omission of preservatives during 24-h of urine collection for the analysis of fractionated metanephrines enhance patient convenience
  39. Transient monoclonal gammopathy in a 2-year-old child with combined viral and bacterial infection
  40. Nephelometric assay of urine free light chains: an alternative and early clinical test for Bence-Jones protein quantification
  41. Congress Abstracts
  42. Congress of Laboratory Medicine and Clinical Chemistry 7th Annual Meeting of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC)
  43. 50th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
  44. Revolution drives Evolution – from measuring to understanding: Annual meeting of Swiss Society of Clinical Chemistry (SSCC) in Bern, November 15-16 2018
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2018-0399/html
Scroll to top button